FDA works with manufacturers to resolve cancer drug shortages

Their efforts have brought the U.S. supply of the chemotherapy cisplatin to nearly 100% of pre-shortage levels, according to a White House press release. The moves are “greatly alleviating the shortages of carboplatin,” too, the White House said.

Amid a shortage of 15 cancer drugs because of manufacturing and supply chain issues, the FDA has been working closely with cancer drug manufacturers to boost production capacity, the White House said.

The regulator has also been angling to bring companies back into the manufacturing fold who’d...